Gyre Therapeutics GYRE
NASDAQ GYRE
$7.11 +0.11 (+1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Shares Outstanding (Diluted) (2010 - 2026)

Updated

Gyre Therapeutics (GYRE) posted Shares Outstanding (Diluted) of 100.64 million for Q2 2026, down 2.0% from 102.7 million a year earlier but up 10.2% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

For FY2025, Gyre Therapeutics' Shares Outstanding (Diluted) came in at 103.18 million, up 0.9% from FY2024.

  • Annual Shares Outstanding (Diluted) shows a five-year compound annual growth rate of 445.5% (FY2020 to FY2025).
  • In prior years, Gyre Therapeutics' Shares Outstanding (Diluted) was 102.29 million in FY2024 (+55.4%), 65.83 million in FY2023, 2.1 million in FY2022 (+3.0%) and 2.04 million in FY2021.
  • Quarterly Shares Outstanding (Diluted) has run from a low of 2.04 million in Q4 2021 to a high of 104.33 million in Q2 2024 over five years.
  • On a year-over-year basis, Shares Outstanding (Diluted) increased in three of the last seven quarters, with growth averaging 6.1%.
  • The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q4 2024, with growth of 55.4%; the weakest was Q1 2026, with a decline of 10.4%.
  • According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 91.34 million (Q1 2026), 103.18 million (Q4 2025) and 103.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.44 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.77 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.56 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.24 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 5.70 Bn
10 Gyre Therapeutics 753.90 Mn 556.61 Mn 26.90 Mn 100.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.64 Mn
Mar 31, 2026 91.34 Mn
Dec 31, 2025 103.18 Mn
Sep 30, 2025 103.97 Mn
Jun 30, 2025 102.70 Mn
Mar 31, 2025 101.97 Mn
Dec 31, 2024 102.29 Mn
Sep 30, 2024 102.64 Mn
Jun 30, 2024 104.33 Mn
Mar 31, 2024 102.59 Mn
Dec 31, 2023 65.83 Mn
Sep 30, 2023 2.53 Mn
Jun 30, 2023 2.52 Mn
Mar 31, 2023 2.53 Mn
Dec 31, 2022 2.10 Mn
Sep 30, 2022 2.10 Mn
Jun 30, 2022 2.10 Mn
Mar 31, 2022 2.10 Mn
Dec 31, 2021 2.04 Mn
Sep 30, 2021 2.09 Mn
API Access

Gyre Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GYRE&period=max&api_key=YOUR_API_KEY